Trials / Completed
CompletedNCT01298973
Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Innovative Medical · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to look at the ability of Viscoat to ensure proper wound closure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Viscoat | One group will receive Viscoat for incision closure |
| DRUG | Saline | One group will receive Saline to irrigate the wound |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2011-02-18
- Last updated
- 2012-01-18
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01298973. Inclusion in this directory is not an endorsement.